Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: Implications in the cornea

Experimental Eye Research

Volumn 78, Issue 5, 2004, Pages 957-971

  Vij, Neeraj ^a   Roberts, Luke ^a   Joyce, Sarah ^a   Chakravarti, Shukti ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cornea; Fas; Immune privilege; Lumican; Proliferation

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN P21; PROTEIN P53; RECOMBINANT LUMMICAN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; CORNEA CELL; CULTURE MEDIUM; EMBRYO; EXTRACELLULAR MATRIX; EYE INJURY; FIBROBLAST; HEALING; INTERMETHOD COMPARISON; INTERSTITIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REDUCTION; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; STROMA; WILD TYPE; WOUND;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CORNEA; FAS LIGAND PROTEIN; FIBROBLASTS; IMMUNE TOLERANCE; KERATAN SULFATE; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; PROTEOCHONDROITIN SULFATES; SIGNAL TRANSDUCTION;

EID: 1642421036     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.12.006     Document Type: Article

References (65)

1. Berger M., Vogt Sionov R., Levine A.J., Haupt Y. A role for the polyproline domain of p53 in its regulation by Mdm2. J. Biol. Chem. 276:2001;3785-3790.
2. Blochberger T., Cornuet P., Hassell J. Isolation and partial characterization of lumican and decorin from adult chicken corneas. J. Biol. Chem. 267:1992;20613-20619.
3. Blochberger T., Vergnes J., Hempel J., Hassell J. cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J. Biol. Chem. 267:1992;347-352.
4. Celis J.E., Madsen P., Celis A., Nielsen H.V., Gesser B. Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division. FEBS Lett. 220:1987;1-7.
5. Chakravarti S., Stallings R.L., SundarRaj N., Cornuet P.K., Hassell J.R. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics. 27:1995;481-488.
6. Chakravarti S., Magnuson T., Lass J., Jepsen K., LaMantia C., Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 141:1998;1277-1286.
7. Chakravarti S., Petroll W., Hassell J., Jester J., Lass J., Paul J., Birk D. Corneal Opacity in Lumican-Null Mice: Defects in Collagen Fibril Structure and Packing in the Posterior Stroma. Invest. Ophthalmol. Vis. Sci. 41:2000;3365-3373.
8. Chakravarti S., Paul J., Roberts L., Oldberg A., Birk D.E. Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest. Ophthalmol. Vis. 44:2003;2422-2932.
9. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer. 3:2003;102-109.
10. Cheng N.C., van de Vrugt H.J., van der Valk M.A., Oostra A.B., Krimpenfort P., de Vries Y., Joenje H., Berns A., Arwert F. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum. Mol. Genet. 9:2000;1805-1811.
11. Coppock D.L., Kopman C., Scandalis S., Gilleran S. Preferential gene expression in quiescent human lung fibroblasts. Cell Growth Differ. 4:1993;483-493.
12. Coppock D., Kopman C., Gudas J., Cina-Poppe D.A. Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29. Biochem. Biophys. Res. Commun. 269:2000;604-610.
13. Csordas G., Santra M., Reed C.C., Eichstetter I., McQuillan D.J., Gross D., Nugent M.A., Hajnoczky G., Iozzo R.V. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem. 275:2000;32879-32887.
14. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:1997;729-743.
15. DeLuca A., Santra M., Baldi A., Giordano A., Iozzo R. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem. 271:1996;18961-18965.
16. Ezura Y., Chakravarti S., Oldberg A., Chervoneva I., Birk D.E. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell Biol. 151:2000;779-788.
17. Ferguson T.A., Green D.R., Griffith T.S. Cell death and immune privilege. Int. Rev. Immunol. 21:2002;153-172.
18. Funderburgh J.L., Conrad G.W. Isoforms of chemical keratan sulfate proteoglycan. J. Biol. Chem. 265:1990;8297-8303.
19. Funderburgh J.L., Funderburgh M.L., Brown S.J., Vergnes J.P., Hassell J.R., Mann M.M., Conrad G.W. Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique. J. Biol. Chem. 268:1993;11874-11880.
20. Funderburgh J.L., Funderburgh M.L., Hevelone N.D., Stech M.E., Justice M.J., Lang C.-Y., Kao W.W., Conrad G.W. Sequence, molecular properties, and chromosomal mapping of mouse lumican. Invest. Ophthal. Vis. Sci. 36:1995;2296.
21. Funderburgh J.L., Mitschler R.R., Funderburgh M.L., Roth M.R., Chapes S.K., Conrad G.W. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest. Ophthalmol. Vis. Sci. 38:1997;1159-1167.
22. Funderburgh J.L., Funderburgh M.L., Mann M.M., Corpuz L., Roth M.R. Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation. J. Biol. Chem. 276:2001;44173-44178.
23. Gao J., Gelber-Schwalb T.A., Addeo J.V., Stern M.E. Apoptosis in the rabbit cornea after photorefractive keratectomy. Cornea. 16:1997;200-208.
24. Griffith T.S., Ferguson T.A. The role of FasL-induced apoptosis in immune privilege. Immunol. Today. 18:1997;240-244.
25. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
26. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
27. Hausser H., Wedekind P., Sperber T., Peters R., Hasilik A., Kresse H. Isolation and cellular localization of the decorin endocytosis receptor. Eur. J. Cell Biol. 71:1996;325-331.
28. Hausser H., Schonherr E., Muller M., Liszio C., Bin Z., Fisher L.W., Kresse H. Receptor-mediated endocytosis of decorin: involvement of leucine-rich repeat structures. Arch. Biochem. Biophys. 349:1998;363-370.
29. Henry S.P., Takanosu M., Boyd T.C., Mayne P.M., Eberspaecher H., Zhou W., de Crombrugghe B., Hook M., Mayne R. Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family. J. Biol. Chem. 276:2001;12212-12221.
30. Iozzo R.V. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem. 274:1999;18843-18846.
31. Iozzo R.V., Moscatello D.K., McQuillan D.J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274:1999;4489-4492.
32. Jepsen K.J., Wu F., Peragallo J.H., Paul J., Roberts L., Ezura Y., Oldberg A., Birk D.E., Chakravarti S. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J. Biol. Chem. 277:2002;35532-35540.
33. Jin S., Levine A.J. The p53 functional circuit. J. Cell Sci. 114:2001;4139-4140.
34. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
35. Leygue E., Snell L., Dotzlaw H., Troup S., Hiller-Hitchcock T., Murphy L.C., Roughley P.J., Watson P.H. Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol. 192:2000;313-320.
36. Lorenzo P., Aspberg A., Onnerfjord P., Bayliss M.T., Neame P.J., Heinegard D. Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J. Biol. Chem. 276:2001;12201-12211.
37. Massague J. How cells read TGF-beta signals. Nat Rev. Mol. Cell Biol. 1:2000;169-178.
38. Mauviel A., Santra M., Chen Y.Q., Uitto J., Iozzo R.V. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. J. Biol. Chem. 270:1995;11692-11700.
39. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
40. Mohan R.R., Liang Q., Kim W.J., Helena M.C., Baerveldt F., Wilson S.E. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp. Eye. Res. 65:1997;575-589.
41. Moscatello D.K., Santra M., Mann D.M., McQuillan D.J., Wong A.J., Iozzo R.V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101:1998;406-412.
42. Rada J.A., Cornuet P.K., Hassell J.H. Regulation of corneal collagen fibrillogenesis in vitro by corneal keratan sulfate proteoglycan (lumican) and decorin core proteins. Exp. Eye Res. 56:1993;635-648.
43. Reed C.C., Gauldie J., Iozzo R.V. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene. 21:2002;3688-3695.
44. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
45. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:2000;3037-3050.
46. Saika S., Shiraishi A., Liu C.Y., Funderburgh J.L., Kao C.W., Converse R.L., Kao W.W. Role of lumican in the corneal epithelium during wound healing. J. Biol. Chem. 275:2000;2607-2612.
47. Santra M., Skorski T., Calabretta B., Lattime E.C., Iozzo R.V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Nat. Acad. Sci. USA. 92:1995;7016-7020.
48. Santra M., Mann D.M., Mercer E.W., Skorski T., Calabretta B., Iozzo R.V. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100:1997;149-157.
49. Santra M., Reed C.C., Iozzo R.V. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J. Biol. Chem. 277:2002;35671-35681.
50. Schrecengost P.K., Blockberger T.C., Hassell J.K. Identification of chick corneal keratan sulfate proteoglycan precursor protein in whole corneas and in cultured corneal fibroblasts. Arch. Biochem. Biophys. 292:1992;54-61.
51. Song J., Lee Y.G., Houston J., Petroll W.M., Chakravarti S., Cavanagh H.D., Jester J.V. Neonatal corneal stromal development in the normal and lumican-deficient mouse. Invest. Ophthalmol. Vis. Sci. 44:2003;548-557.
52. Stander M., Naumann U., Dumitresco L., Heneka M., Loschmann P., Gulbins E., Dickgans J., Weller M. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther. 5:1998;1187-1194.
53. SunderRaj N., Fite D., Delak R., SunderRaj S., Rada J., Okamoto S., Hassell J. Proteoglycan distribution during healing of corneal stromal wounds in chick. Exp. Eye Res. 67:1998;433-442.
54. Svensson L., Aszodi A., Reinholt F.P., Fassler R., Heinegard D., Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J. Biol. Chem. 274:1999;9636-9647.
55. Svensson L., Narlid I., Oldberg A. Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett. 470:2000;178-182.
56. Tasheva E.S., Maki C.G., Conrad A.H., Conrad G.W. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. Biochim. Biophys. Acta. 1517:2001;333-338.
57. Tasheva E.S., Koester A., Paulsen A.Q., Garrett A.S., Boyle D.L., Davidson H.J., Song M., Fox N., Conrad G.W. Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol. Vis. 8:2002;407-415.
58. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
59. Troup S., Njue C., Kliewer E.V., Parisien M., Roskelley C., Chakravarti S., Roughley P.J., Murphy L.C., Watson P.H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9:2003;207-214.
60. Vogel K.G., Paulsson M., Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycans of tendon. Biochem. J. 223:1984;587-597.
61. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
62. Wilson S.E., Li Q., Weng J., Barry-Lane P.A., Jester J.V., Liang Q., Wordinger R.J. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest. Ophthalmol. Vis. Sci. 37:1996;1582-1592.
63. Wulf G.M., Liou Y.C., Ryo A., Lee S.W., Lu K.P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:2002;47976-47979.
64. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor B by the proteoglycan decorin. Nature. 346:1990;281-284.
65. Zieske J.D., Guimaraes S.R., Hutcheon A.E. Kinetics of keratocyte proliferation in response to epithelial debridement. Exp. Eye Res. 72:2001;33-39.